Drug intelligence / Profile preview

Bao Jin Chen Fei Granules

Development stage: Unknown
Lead developer: Henan University of Chinese Medicine
Modality: Small Molecules
Administration: Oral

Overview

Bao Jin Chen Fei Granules is a traditional Chinese medicine (TCM) compound formulation developed by the Henan University of Traditional Chinese Medicine for the treatment of Coal Worker's Pneumoconiosis (CWP). It is specifically designed to treat patients presenting with the TCM "syndrome of pulmonary qi deficiency." The formulation is manufactured as granules by Sichuan Neo-Green Pharmaceutical Technology Development Co., Ltd. and is administered orally. In clinical research, it is evaluated for its potential to improve clinical efficacy and respiratory function when used in combination with standard symptomatic treatments for pneumoconiosis.

Other names: Bao Jin Chen Fei

Beyond the preview

Go deeper on Bao Jin Chen Fei Granules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bao Jin Chen Fei Granules.

Explore the full profile